학술논문
Examining the risk of breakthrough infection and COVID‐19 vaccination safety in patients with atopic dermatitis.
Document Type
Article
Source
Subject
*BREAKTHROUGH infections
*COVID-19
*COVID-19 vaccines
*ATOPIC dermatitis
*PATIENT safety
*HEART failure
*
*
*
*
*
Language
ISSN
0007-0963
Abstract
It is unknown whether COVID-19 vaccination is associated with increased side-effects or breakthrough infection with COVID-19 in patients with AD, and therefore our goal was to evaluate this using multicentre data. Examining the risk of breakthrough infection and COVID-19 vaccination safety in patients with atopic dermatitis Dear Editor, As of November 2021, the BNT162b2, mRNA-1273 and Ad26.COV2.S COVID-19 vaccines have been granted emergency-use authorization in the USA by the Food and Drug Administration (FDA).1-3 While these vaccines have shown safety and success in preventing COVID-19 infection in healthy participants, many studies excluded immunocompromised people and those with chronic inflammation. [Extracted from the article]